• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Pharmacists could dramatically reduce ER visits

Bioengineer by Bioengineer
January 10, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Incorporating pharmacists with an expanded scope into the community or hospital emergency departments (ED) could significantly reduce ED crowdedness, according to a new study.

Researchers from the University of Waterloo found that almost one-third of non-urgent ED visits in Ontario were for conditions that could potentially be managed by pharmacists with an expanded scope of practice – available in other jurisdictions in Canada.

“Overcrowding in EDs is a concern most Canadians can relate to, and we know that it can lead to increased mortality and a higher rate of patients who leave without receiving treatment,” said Wasem Alsabbagh, a professor at the Waterloo School of Pharmacy. “Our findings support that we need to see more pharmacists working with expanded scope in community practice or based in the ED. This may reduce crowdedness and free more resources in EDs to care for more acute patients.”

As about one in five patients who seek emergency care have non-urgent health concerns, the study examined what proportion of non-urgent or unnecessary visits could be potentially managed by a pharmacist. The researchers analyzed data from 2010 to 2017, examining all Ontario hospital ED cases. They qualified cases based on standard scales that measure the severity of patient concerns and used statistics to assess which ones could be managed by pharmacists working with an expanded scope.

The services pharmacists can provide have been expanding in Canada over the last decade, though there is significant variety – both in the rate and scope – between provinces. In Alberta, for example, pharmacists were granted the ability since 2007 to prescribe both independently and for minor ailments, renew prescriptions, administer injections, and more. Ontario has expanded scope more slowly with the addition of services like prescriptions renewal and influenza vaccination in 2012. More vaccines were added later in 2016.

“Our study included all expanded scope services in use across Canada when assessing which ED cases pharmacists could manage,” said Alsabbagh. “Over the seven years of the study period, we found that pharmacists with an expanded scope could potentially have managed nearly 1.5 million cases in Ontario.”

The most frequent ED cases that could be managed by a pharmacist included skin related concerns like dermatitis and other conditions like a cough or inflammation of the ear canal, nasal passages, and throat.

The study by Waterloo professors Wasem Alsabbagh and Sherilyn Houle is called The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with an expanded scope of practice and was recently published in the journal Research in Social and Administrative Pharmacy.

###

Media Contact
Matthew Grant
[email protected]
226-929-7627

Tags: Critical Care/Emergency MedicineHealth Care Systems/ServicesMedicine/HealthPharmaceutical ChemistryPharmaceutical SciencePublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Tirzepatide Outperforms GLP-1 RAs in Diabetes Care

August 28, 2025

BindCraft Enables One-Shot Functional Protein Binders

August 28, 2025

Assessing NIPAM Gel Sensitivity in CyberKnife Dosimetry

August 28, 2025

Lipid Timing: Impact on Menopausal Symptoms Explored

August 28, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    149 shares
    Share 60 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tirzepatide Outperforms GLP-1 RAs in Diabetes Care

BindCraft Enables One-Shot Functional Protein Binders

Assessing NIPAM Gel Sensitivity in CyberKnife Dosimetry

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.